CURRENT NEWS

People with lupus know there’s no cure for their condition. Treatment options usually include medications to prevent flare-ups and manage symptoms, but nothing to effectively control the disease progression.

A major cause of inflammatory bowel disease (IBD) has been discovered, and could be treated with existing drugs.

A pooled analysis of prior trial data showed semaglutide reduced the risk of heart failure worsening.

An imbalance of T cells, which play a key role in the body’s immune response, could explain most cases of the disease, according to new research.

Scientists have identified a gene which, when missing or impaired, can cause obesity, behavioural problems and, in mothers, postnatal depression. The discovery, reported today in Cell, may have wider implications for the treatment of postnatal depression, with a study in mice suggesting that oxytocin may alleviate symptoms.

Using a combination of cutting-edge immunologic technologies, researchers have successfully stimulated animals' immune systems to induce rare precursor B cells of a class of HIV broadly neutralizing antibodies (bNAbs).

The company’s experimental drug was shown in a clinical trial to slow cognitive decline by 35 percent in early disease stages.

Could make early Alzheimer’s diagnosis, treatment accessible to more people.

In the ever-evolving healthcare landscape, social determinants of health (SDOH) are pivotal factors in influencing patient outcomes.

Preliminary results were presented this week at a cancer research conference in California and showed that a type of blood test called a “liquid biopsy” was key to achieving a 97% accuracy rate at diagnosing the most common type of pancreatic cancer during early stages.

After weight-loss drugs like Ozempic exploded onto the market, celebrities and social media influencers were quick to spruik their benefits, leading to their rapid rise in use. In the last three months of 2022, clinicians in the United States alone wrote more than nine million prescriptions for these drugs.

Dedicated memory tests on smartphones enable the detection of "mild cognitive impairment," a condition that may indicate Alzheimer's disease, with high accuracy. Researchers from DZNE, the Otto-von-Guericke University Magdeburg and the University of Wisconsin-Madison who collaborated with the Magdeburg-based company Neotiv report these findings in npj Digital Medicine. Their study is based on data from 199 older adults.

This investment would be used to create a Fund for Women’s Health Research at the National Institutes of Health (NIH) to advance a cutting-edge, interdisciplinary research agenda and to establish a new nationwide network of research centers of excellence and innovation in women’s health—which would serve as a national gold standard for women’s health research across the lifespan.

The complete response letter outlined several objections raised by agency reviewers, and indicated Minerva must conduct at least one additional “well-controlled” trial.

The groundbreaking approval has been eagerly anticipated by patients and doctors alike. The treatment is priced at $2.2 million per person.

TIL therapy shrank tumors in about a third of patients who had run out of treatment options, according to a clinical trial.

People who are suffering from severe pain but don’t want to risk addiction to an opioid are closer to a new option for treatment.

Each shot would be completely personalized to the patient.

The Food and Drug Administration says 561 deaths have been reported in connection to recalled Philips devices to treat obstructive sleep apnea and other breathing disorders.

Bayer said its menopausal relief drug eased hot flashes and improved sleep

A new trial finds that LSD might have the potential to treat anxiety.

Here’s what a new clinical trial says.

Pfizer shares sank Friday when the drugmaker announced that it was abandoning a twice-daily obesity treatment after more than half the patients in a clinical trial stopped taking it

Uncover the potential benefits of ginger supplements in the fight against autoimmune conditions.

Early clinical trial results showed Verve’s therapy can substantially lower cholesterol levels by editing the genes of liver cells.

Here’s why that’s a problem.

Pyrotinib combo demonstrates remarkable efficacy for HER2 positive metastatic breast cancer

Vigil Neuroscience has dosed the first subject in a Phase I clinical trial of VG-3927 to potentially treat Alzheimer’s disease (AD).

Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial

Recruit patients faster, retain more of them, and get their outcomes data sooner

Trials show new cancer vaccine could improve patient survival for some lung cancers by nearly half

The nasal spray was more effective at sending patients into remission

The company is planning to start a Phase 3 trial of the vaccine this year, and is targeting a regulatory approval in 2025.

Boundless Bio has announced a collaboration with Eli Lilly for its first-in-human Phase I/II trial investigating BBI-355 in solid tumours.

​

​

​

NIH-funded clinical trial finds cholesterol-lowering treatment reduced cardiovascular events by 35%.

​

​

​

The drugs could hit the market in 2024.

​

Experimental drug could offer more weight loss than any drug now on the market, study finds

​

The drugmaker is discontinuing work on brazikumab, an IL-23 inhibitor it regained rights to following AbbVie’s acquisition of Allergan.

A novel, non-invasive treatment using electrical currents exploits physiological properties of dividing cancer cells to prolong survival and augment current therapies.

Although pain affects millions of people worldwide, the industry is still struggling in the ongoing search for safe and effective medication.

Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial